A STUDY ON THE GLYCEMIC STATUS AND OUTCOME OF PATIENTS WITH COVID ASSOCIATED MUCORMYCOSIS.

Simple item page
dc.contributor.authorBalamanikandan, Dr. P.en_US
dc.contributor.authorAnusuya, Dr. M.en_US
dc.contributor.authorDevi, Dr. R. Sharmilaen_US
dc.contributor.authorKumar, Dr. S. Sunilen_US
dc.contributor.authorPriyanka, Dr. B.en_US
dc.contributor.authorV. S., Dr. Bermio.en_US
dc.date.accessioned2023-08-09T05:39:06Z
dc.date.available2023-08-09T05:39:06Z
dc.date.issued2022-03
dc.description.abstractBackground:A surge of mucormycosis during the second wave of COVID intrigued the doctors in India to look for the epidemiology of the illness.Diabetes is the most common risk factor for mucormycosis.COVID can cause hyperglycemia due to various reasons.In this study,we describe the outcome of post COVID mucormycosis with respect to the glycemic status of the patient. (1)To describe the glycemic parameters of patients with COVID-19 Associated M Objectives: ucormycosis.(2)To describe the one month outcome of the patients.(3)To compare patients with Newly Diagnosed Diabetes Mellitus Post COVID-19 and patients having preexisting diabetes mellitus. 75 patients with probable or proven mucormycosis wit Methodology: h history of COVID atleast 2 weeks before were randomly selected from the mucor ward of Rajiv Gandhi Government General Hospital and their glycemic profile assessed.They were followed up for one month and the results were statistically analyzed. Regarding the prior CO Results: VID illness,patients had a median hospital stay of 7 days,received 5 days of intravenous steroids and 3.48 days of supplemental oxygen.Patients who had hyperglycemia during COVID also had statistically significantly higher iv steroid use and higher need for oxygen.There was a statistically very significant(p<0.001) increase in the number of diabetics post COVID(from 57.3% prior to COVID to 90.7% post COVID).Majority of the Mucormycosis patients(69.3%) had severe hyperglycemia during presentation.Pre-existing diabetics had a statistically significant higher incidence of sepsis and renal failure during treatment for mucormycosis.Otherwise,there was no significant difference in outcome between various grades of severity of hyperglycemia,and no distinction was found between pre-existing diabetics and newly diagnosed diabeticsen_US
dc.identifier.affiliationsMD Assistant Professor, Institute of Internal Medicine, Madras Medical College, Chennaien_US
dc.identifier.affiliationsProfessor, MD, Institute of Internal Medicine, Madras Medical Collegeen_US
dc.identifier.affiliationsAssistant Professor, MD, Institute of Internal Medicine, Madras Medical College, Chennaien_US
dc.identifier.affiliationsMBBS, Junior Resident, Institute of Internal Medicine, Madras Medical Collegeen_US
dc.identifier.affiliationsMBBS, Junior Resident, Institute of Internal Medicine, Madras Medical Collegeen_US
dc.identifier.affiliationsMBBS, Junior Resident, Institute of Internal Medicine, Madras Medical College. *Corresponding Authoren_US
dc.identifier.citationBalamanikandan Dr. P., Anusuya Dr. M., Devi Dr. R. Sharmila, Kumar Dr. S. Sunil, Priyanka Dr. B., V. S. Dr. Bermio.. A STUDY ON THE GLYCEMIC STATUS AND OUTCOME OF PATIENTS WITH COVID ASSOCIATED MUCORMYCOSIS.. Indian Journal Of Applied Research. 2022 Mar; 12(3): 11-14en_US
dc.identifier.issn2249-555X
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/221132
dc.languageenen_US
dc.publisherIndian Society For Health And Advanced Researchen_US
dc.relation.issuenumber3en_US
dc.relation.volume12en_US
dc.source.urihttps://www.doi.org/10.36106/ijar/1700437en_US
dc.subjectMucormycosisen_US
dc.subjectpost covid diabetesen_US
dc.subjectglycemic statusen_US
dc.titleA STUDY ON THE GLYCEMIC STATUS AND OUTCOME OF PATIENTS WITH COVID ASSOCIATED MUCORMYCOSIS.en_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IJAR2022v12n3p11.pdf
Size:
467.76 KB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal Of Applied Research